Recursion Pharmaceuticals Inc (RXRX)
6.415
-0.12
(-1.76%)
USD |
NASDAQ |
Mar 26, 10:03
Recursion Pharmaceuticals Total Liabilities (Quarterly): 413.82M for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Absci Corp | 34.48M |
| Corcept Therapeutics Inc | 160.96M |
| Catalyst Pharmaceuticals Inc | 123.78M |
| Enanta Pharmaceuticals Inc | 236.83M |
| Apellis Pharmaceuticals Inc | 656.51M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.449B |
| Shareholders Equity (Quarterly) | 1.035B |
| Debt to Equity Ratio | 0.0265 |
| Current Ratio | 3.81 |
| Net Debt Paydown Yield | -0.19% |